A proposed merger, acquisition or joint venture requires much more than a legal and accounting review. It requires an in-depth understanding of the target’s products and business practices, as well as the target’s reputation in the market.
As we’ve been providing insights to venture capital and private equity firms in the life science industry for nearly twenty years, we know that scientific customers provide an objective perspective against which the target’s claims can be compared. We’ve also found that customers are willing to share their likely reaction to the acquisition of their preferred supplier and what will cause them to switch.
Here’s a few examples:
Information Source: http://archive.gene2drug.com/?page=whatsnew&id=74